Latham & Watkins LLP represented the underwriters in the offering. Kronos Bio, Inc. has announced the pricing of its initial public offering of 13,157,895 shares of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
